214 related articles for article (PubMed ID: 17475902)
1. Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter.
Nakai Y; Inoue K; Abe N; Hatakeyama M; Ohta KY; Otagiri M; Hayashi Y; Yuasa H
J Pharmacol Exp Ther; 2007 Aug; 322(2):469-76. PubMed ID: 17475902
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model.
Inoue K; Nakai Y; Ueda S; Kamigaso S; Ohta KY; Hatakeyama M; Hayashi Y; Otagiri M; Yuasa H
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G660-8. PubMed ID: 18174275
[TBL] [Abstract][Full Text] [Related]
3. The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs.
Urquhart BL; Gregor JC; Chande N; Knauer MJ; Tirona RG; Kim RB
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G248-54. PubMed ID: 19762432
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
5. Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
Biswal BK; Verma RS
J Biochem; 2009 Nov; 146(5):693-703. PubMed ID: 19692428
[TBL] [Abstract][Full Text] [Related]
6. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption.
Qiu A; Jansen M; Sakaris A; Min SH; Chattopadhyay S; Tsai E; Sandoval C; Zhao R; Akabas MH; Goldman ID
Cell; 2006 Dec; 127(5):917-28. PubMed ID: 17129779
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
8. The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed.
Zhao R; Goldman ID
Cancer Metastasis Rev; 2007 Mar; 26(1):129-39. PubMed ID: 17340171
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
10. Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.
Yokooji T; Mori N; Murakami T
J Pharm Pharmacol; 2009 Jul; 61(7):911-8. PubMed ID: 19589233
[TBL] [Abstract][Full Text] [Related]
11. Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia.
Subramanian VS; Marchant JS; Said HM
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C233-40. PubMed ID: 18003745
[TBL] [Abstract][Full Text] [Related]
12. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
14. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
[TBL] [Abstract][Full Text] [Related]
15. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
16. Transport of methotrexate into PC-3 human prostate cancer cells.
Horne DW; Reed KA
Arch Biochem Biophys; 2001 Oct; 394(1):39-44. PubMed ID: 11566025
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate influx via folate transporters into alveolar epithelial cell line A549.
Kawami M; Miyamoto M; Yumoto R; Takano M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):276-81. PubMed ID: 26190800
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier.
Nozaki Y; Kusuhara H; Endou H; Sugiyama Y
J Pharmacol Exp Ther; 2004 Apr; 309(1):226-34. PubMed ID: 14722319
[TBL] [Abstract][Full Text] [Related]
19. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
20. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
McGuire JJ; Haile WH; Yeh CC
Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]